A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro

Clinical trial NCT00662857 · COMPLETED

Trial details

NCT number: NCT00662857
Sponsor: Mannkind Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus: Type 1

Start date: 2008-04-01
Primary completion: 2008-11-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.